Tommy its not HYPE, its called a PH 3 data release
IF you have been investing in bios, you should know that
clinical trials try to 'prove' something. And if they are successful,
likely to lead to an increase in revenues (note, not every development
is actually a revenue generator, ask Sony and their BETA development vs
VHS)
So out of curiosity, why are you claiming this is all 'hype'??
The PH 3 data will answer the first question of, does it work or not.
The next few questions if the data is good, will be, will it 'sell' and how
much (volume of sales), and for 'how much' (profits). While I dislike reverse
splits when they are done at the wrong time, one positive is, the severely reduced
share count can make things a bit more exciting (less shares to spread any profits against)
going forward..
and a disclaimer: yes, I held no shares when the r/split occurred, and didn't start buying
until the share price had fallen below $5/sh.
Here's hoping the PH 3 data is good, especially for those that could benefit from its development
They already have a life changing event in progress, and anything that makes it easier to deal with,
you have to hope for their sake, it happens